Neuro headbands: the €500 placebo with great Instagram lighting
Apollo, Sensate, Muse, Pulsetto — the at-home "vagus nerve stimulators" cost more than therapy and do less than a 4-7-8 breath. Here's what the actual data says.
Scorecard
- Potency — Mixed. Transcutaneous vagus stimulation does measurably affect vagal afferents in the right placement.
- Bioavailability — Strong. Direct nerve stimulation, no metabolism in the way.
- Marketing vs hype vs reality — Weak. "Rewires your brain" and HRV-as-fitness-score language outruns the clinical evidence at consumer doses.
- Sustainability — Weak. Electronics e-waste, lithium battery, no repair pathway, locked accessories.
- Ethics — Mixed. €400–€700 price gates real-world access; subscription-locked premium features after purchase.
Verdict: Avoid. Free breathwork shifts vagal tone more reliably and trains the skill, not the dependency.
The wellness device aisle is now full of small expensive objects you wear, hold, or stick to your forehead. Apollo Neuro vibrates on your wrist. Sensate hums on your sternum. Pulsetto clips to your neck. Muse measures your meditation. They all promise the same thing: calm your nervous system without effort. They all cost €300–€600. And they all rely on one shared trick — they make you slow down for 20 minutes, which is the actual intervention.
The device isn't doing the work. The 20 minutes of sitting still and breathing is doing the work. The device is the excuse.
What's actually true. Real, medical-grade transcutaneous vagus nerve stimulation (tVNS) exists. It's an FDA-cleared therapy for epilepsy and treatment-resistant depression, delivered through specific ear or neck electrodes at specific frequencies. The published trials are on those clinical devices. The consumer wearables borrow the language but rarely the protocol.
What the consumer device studies actually show. Most of the published evidence on consumer wearables is small (10–50 people), unblinded (you obviously know if a device is vibrating on you), industry-funded, and measures soft outcomes like "self-reported stress" — the most placebo-sensitive outcome variable in medicine. Where blinded trials exist, the effect size shrinks dramatically. Heart rate variability changes during use are real but transient, and roughly comparable to what you'd get from a 5-minute box-breathing session.
This doesn't mean the devices "do nothing." It means they do roughly what any 20-minute structured pause would do — and the structured pause is the medicine.
Calling slow breathing "vagal toning" doesn't make a €450 device better than a free breath. It just makes the device sound more medical.
The polyvagal bit, properly. Your vagus nerve is genuinely the master switch between sympathetic (fight/flight) and parasympathetic (rest/digest) tone. You can absolutely train it. The cheapest, most-studied way: extended exhale breathing (inhale 4, exhale 6–8) for 5–10 minutes, daily. Cold-water face immersion. Humming or singing. Slow nasal breathing. None of these require a device. All of them have more evidence than any wearable on the market.
Who actually benefits from the devices. People who genuinely will not sit still without an object telling them to. People who use the device as a habit-anchor (you put it on, you breathe, you feel better — fine, the habit is what's working). People with specific conditions using clinician-prescribed tVNS for an FDA-cleared indication. That last group is the only one where the device itself is doing the work.
Who should walk away. Anyone spending €500 they don't have on a "biohack" they've seen on a podcast. Anyone using it instead of therapy, sleep, or basic exercise. Anyone who would benefit more from a weighted eye pillow and a breath-pacing app, which is most people.
Bottom line. The cheaper your nervous-system tool, the more likely it's the active ingredient. We're stocking the unsexy, evidence-backed swaps — weighted eye pillows, simple breath-pacing trainers — in the shop below.
Kokorology goes long on polyvagal theory itself. The clean tools we'd actually buy are here.
- Potency
- Weak. Most consumer 'vagus nerve stimulators' do not actually stimulate the vagus at the intensities a real tVNS device uses.
- Bioavailability
- Weak. Transcutaneous current at consumer-safe doses is mostly indistinguishable from a warm-vibrating object.
- Marketing vs hype vs reality
- Poor. The clinical tVNS literature is being borrowed wholesale for products that do not match the protocols.
- Sustainability
- Weak. Lithium batteries, single-product devices, planned obsolescence.
- Ethics
- Poor. Anxiety marketing is the funnel. A 4-7-8 breath outperforms most of these for free.
- Verdict
- A EUR 500 placebo with great Instagram lighting.
